Global Immunoassay Market Size By Type (ELISA, Rapid Tests), By Application (Hospitals, Clinical Laboratories), By Region, And Segment Forecasts, 2023 to 2032

The Global Immunoassay Market was valued at USD 28.4 billion in 2023 and is projected to reach USD 47.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.9% from 2023 to 2031. Immunoassays are essential diagnostic tools widely used in clinical laboratories, hospitals, and research institutions to detect and quantify specific proteins, hormones, or pathogens in biological samples. The increasing incidence of infectious and chronic diseases, rising awareness regarding early disease detection, and advancements in immunoassay technology are key drivers accelerating market expansion.

Drivers:

1. Rising Prevalence of Infectious and Chronic Diseases:

The growing global burden of diseases like cancer, diabetes, and infectious outbreaks has amplified the demand for accurate, rapid, and high-throughput diagnostic testing—driving significant uptake of immunoassays.

2. Advancements in Immunoassay Technologies:

Technological improvements such as chemiluminescent immunoassays (CLIA), multiplexed assays, and automated platforms have enhanced test accuracy, sensitivity, and scalability—catalyzing the market growth.

3. Growth in Point-of-Care (POC) Testing:

The shift toward decentralized healthcare and the need for immediate diagnostic results are boosting the adoption of immunoassay-based POC devices, particularly in remote and resource-limited settings.

Restraints:

1. High Cost of Advanced Systems:

Sophisticated immunoassay analyzers and reagent kits come with high procurement and maintenance costs, which can be prohibitive for smaller diagnostic centers in low- and middle-income countries.

2. Stringent Regulatory Frameworks:

The market faces challenges due to strict approval requirements and compliance mandates from regulatory bodies such as the FDA and EMA, which can delay product launches and restrict innovation.

Opportunity:

1. Emerging Markets and Decentralized Diagnostics:

The rapid development of healthcare infrastructure in Asia-Pacific, Latin America, and the Middle East & Africa offers lucrative opportunities. Increased funding and government initiatives are enhancing diagnostic accessibility and driving adoption.

2. Personalized Medicine and Biomarker Discovery:

The rising trend of personalized medicine is creating demand for immunoassays tailored to detect specific biomarkers, thus expanding the scope of their application in oncology, cardiology, and neurology.

Market by System Type Insights:

Based on system type, the Chemiluminescent Immunoassay (CLIA) segment held the largest market share in 2023. CLIA systems are preferred for their high sensitivity, wide dynamic range, and automation compatibility. Meanwhile, the Lateral Flow Immunoassay (LFIA) segment is poised for the fastest growth, driven by increasing deployment in rapid testing and self-diagnosis, particularly during public health emergencies.

Market by End-use Insights:

In 2023, the Hospital Laboratories segment dominated the market due to high patient volumes and the availability of advanced laboratory infrastructure. However, the Point-of-Care Testing segment is expected to register robust growth, spurred by the global shift toward home-based care, faster diagnosis, and minimally invasive testing solutions.

Market by Regional Insights:

North America led the global immunoassay market in 2023, supported by advanced healthcare infrastructure, high R&D investment, and a strong presence of market players. Asia-Pacific is projected to exhibit the fastest growth rate, driven by expanding diagnostic capabilities, increased disease awareness, and growing investments in healthcare infrastructure across countries like China, India, and South Korea.

Competitive Scenario:

Major players operating in the Global Immunoassay Market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, bioMérieux, Ortho Clinical Diagnostics, Becton, Dickinson and Company, Quidel Corporation, and PerkinElmer Inc. These companies are focused on strategic collaborations, product innovation, and regional expansion. Recent developments include:

March 2024: Roche Diagnostics launched a fully automated CLIA platform designed for high-throughput hospital laboratories.

January 2024: Abbott introduced a next-gen lateral flow immunoassay for at-home COVID-19 and influenza co-testing.

October 2023: Siemens Healthineers acquired a diagnostics startup specializing in AI-powered immunoassay interpretation tools.

Scope of Work – Global Immunoassay Market

Report Metric Details

Market Size (2023) USD 28.4 billion

Projected Market Size (2031) USD 47.9 billion

CAGR (2023–2031) 6.9%

Market Segments By System Type, End-use, Region

Growth Drivers Rise in infectious/chronic diseases, tech advancements

Opportunities Personalized medicine, emerging markets

Key Market Developments:

March 2024: Roche launched a next-gen automated immunoassay analyzer with improved multiplexing capabilities.

January 2024: Abbott expanded its global distribution network for lateral flow immunoassays in Africa and Southeast Asia.

November 2023: bioMérieux unveiled a new range of infectious disease biomarkers for immunoassay panels aimed at pandemic preparedness.

FAQs:

1) What is the current market size of the Global Immunoassay Market?

The market was valued at USD 28.4 billion in 2023.

2) What is the major growth driver of the Global Immunoassay Market?

The key driver is the rising prevalence of infectious and chronic diseases along with advancements in immunoassay technologies.

3) Which is the largest region during the forecast period in the Global Immunoassay Market?

North America is the largest region, supported by strong diagnostic infrastructure and high adoption of innovative testing solutions.

4) Which segment accounted for the largest market share in the Global Immunoassay Market?

The Chemiluminescent Immunoassay (CLIA) segment held the largest share in 2023.

5) Who are the key market players in the Global Immunoassay Market?

Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and Danaher Corporation.